The management of biosafety risk in clinical laboratory of hospital during the outbreak of 2019 Novel Coronavirus disease
- VernacularTitle: 新型冠状病毒疫情下医院检验科的生物安全实施方案探讨
- Author:
Yuling XIAO
1
;
Xiaojun LU
1
;
Mei KANG
1
;
Dongdong LI
1
;
Hong JIANG
1
;
Jie CHEN
1
;
Binwu YING
1
;
Yi XIE
1
Author Information
- Publication Type:Journal Article
- Keywords: Coronavirus; Coronavirus infections; Severe acute respiratory syndrome; Communicable disease control
- From: Chinese Journal of Laboratory Medicine 2020;43(0):E010-E010
- CountryChina
- Language:Chinese
- Abstract: During the outbreak of coronavirus disease-19 (COVID-19), the clinical laboratories of hospitals designated for the disease treatment is undertaking a lot of clinical testing work of infectious specimens. How to manage the biosafety risk is a major problem that the clinical laboratory and the nosocomial infection control department are facing. This article introduces the hierarchical prevention and control biosafety measures in the clinical laboratory from the perspective of the laboratory, with a view to provide reasonable and feasible methods for the clinical laboratories of hospitals at various levels during the outbreak.
